Finance

Beta
Lists
PLRX:NASDAQ
Pliant Therapeutics Inc
$1.26
+0.80%
(+0.0100) 1D
$1.24
-1.59% (-0.020)
After hours
Closed: May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PLRX...
Open
$1.25
High
$1.28
Low
$1.24
Mkt. cap
78.02M
Avg. vol.
520.42K
Volume
315.28K
52-wk high
$1.95
52-wk low
$1.09
EPS
-$1.84
Beta
1.20
Shares outstanding
61.92M
No. of employees
49
Open
$1.25
High
$1.28
Low
$1.24
Mkt. cap
78.02M
Avg. vol.
520.42K
Volume
315.28K
52-wk high
$1.95
52-wk low
$1.09
EPS
-$1.84
Beta
1.20
Shares outstanding
61.92M
No. of employees
49
News stories
From sources across the web
About Pliant Therapeutics Inc
CEO-
Employees49
Founded2015
HeadquartersSouth San Francisco, California, United States
SectorPharmaceutical industry
Websitepliantrx.com
Last report
May 11, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.32 / -$0.36
+10.60%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
32.20M
17.84M
13.38M
13.58M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.39M
10.33M
7.69M
8.19M
Operating expense
45.59M
28.17M
21.08M
21.77M
Total operating expenses
45.59M
28.17M
21.08M
21.77M
Operating income
-45.59M
-28.17M
-21.08M
-21.77M
Other non operating income
-
-
-
-
EBT including unusual items
-43.30M
-26.30M
-23.58M
-20.04M
EBT excluding unusual items
-43.30M
-26.20M
-19.25M
-20.04M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-43.30M
-26.30M
-23.58M
-20.04M
Net profit margin
-
-
-
-
Earnings per share
-0.71
-0.43
-0.35
-0.32
Interest and investment income
3.10M
2.78M
1.96M
1.73M
Interest expense
-809.00K
-815.00K
-136.00K
-
Net interest expenses
2.29M
1.97M
1.83M
1.73M
Depreciation and amortization charges
-
-
-
-
EBITDA
-45.14M
-27.73M
-20.71M
-21.51M
Gain or loss from assets sale
-
-44.00K
-
-94.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer